AS

Abhay Sadashiv Sapre

Active Director Additional Director DIN 10804027
DIN 10804027 First appointment Oct 2024 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Oct 2024
Shareholding value - Across - companies

About Abhay Sadashiv Sapre

Abhay Sadashiv Sapre has 1 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Ftf Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10804027
Primary Designation Additional Director
First Appointment 10 Oct 2024
Oldest Company Age 14 yrs

Current companies

Company Designation Appointment Founded Status
Ftf Pharma Private Limited U24230GJ2012PTC070818
Additional Director 10 Oct 2024 2012 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ftf Pharma Private Limited

Shareholding

Pro
Shareholding preview is available in the premium director profile.

Shares held, value and quarterly changes across all companies — with the full investment profile.

Unlock shareholding

Frequently Asked Questions about Abhay Sadashiv Sapre

Abhay Sadashiv Sapre has 1 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Ftf Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Abhay Sadashiv Sapre is associated with 1 company as Additional Director.

Abhay Sadashiv Sapre has expertise in General Business.

Abhay Sadashiv Sapre has 1 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available